PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW145462View Pathway |
drug action
Zinc Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:52 Last Updated: October 07, 2023 at 15:52 |
PW132215View Pathway |
Zinc gluconate Drug MetabolismHomo sapiens
Zinc gluconate is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Zinc gluconate passes through the liver and is then excreted from the body mainly through the kidney.
|
Creator: Ray Kruger Created On: September 21, 2023 at 20:11 Last Updated: September 21, 2023 at 20:11 |
PW146318View Pathway |
drug action
Zinc gluconate Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:55 Last Updated: October 07, 2023 at 17:55 |
PW146088View Pathway |
drug action
Zinc oxide Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:23 Last Updated: October 07, 2023 at 17:23 |
PW132211View Pathway |
Zinc phenolsulfonate Drug MetabolismHomo sapiens
Zinc phenolsulfonate is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Zinc phenolsulfonate passes through the liver and is then excreted from the body mainly through the kidney.
|
Creator: Ray Kruger Created On: September 21, 2023 at 20:09 Last Updated: September 21, 2023 at 20:09 |
PW146940View Pathway |
drug action
Zinc phenolsulfonate Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 19:24 Last Updated: October 07, 2023 at 19:24 |
PW146089View Pathway |
drug action
Zinc sulfate Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:23 Last Updated: October 07, 2023 at 17:23 |
PW146848View Pathway |
drug action
Zinc sulfate, unspecified form Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 19:11 Last Updated: October 07, 2023 at 19:11 |
PW128071View Pathway |
drug action
Ziprasidone Dopamine Antagonist Action PathwayHomo sapiens
Ziprasidone is an atypical antipsychotic used to treat schizophrenia, bipolar mania, and acute agitation in schizophrenic patients. It also indicated improvement on the manic syndrome subscale that measures symptoms of mania such as mood, insomnia, excessive energy and activity, and overall behavior and ideation. Ziprasidone is also used as off-labeled for monotherapy in acute hypomania, monotherapy as maintenance treatment for adult patients with bipolar I disorder, hyperactivity treatment, and for the treatment of delirium in the ICU. Ziprasidone presents in both oral capsule and intramuscular injection formulations. Ziprasidone is an atypical antipsychotic that has a binding affinity for dopaminergic (DA), serotonergic (5HT), adrenergic (a1), and histaminergic (HA) receptors. Regarding treatment for schizophrenia, antagonism of the dopamine (D2) receptor in the mesolimbic pathway has proven efficacious in diminishing positive symptoms, whereas the antagonism of the 5HT2A receptor in the mesocortical pathway has demonstrated reduction of negative symptoms of psychosis. Its efficacy and mechanism of action for treating bipolar disorder are unknown. The antagonization of both histaminergic and adrenergic (a1) receptors can induce somnolence and orthostatic hypotension.
|
Creator: Omolola Created On: July 13, 2023 at 09:43 Last Updated: July 13, 2023 at 09:43 |
PW144375View Pathway |
drug action
Ziprasidone Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 13:30 Last Updated: October 07, 2023 at 13:30 |